These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29538453)

  • 1. Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.
    Nam YH; Brensinger CM; Bilker WB; Leonard CE; Kasner SE; Grosser T; Li X; Hennessy S
    PLoS One; 2018; 13(3):e0193800. PubMed ID: 29538453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.
    Lin CC; Hu HY; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1119-28. PubMed ID: 24099473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
    Rahme E; Nedjar H
    Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety of Clopidogrel vs Aspirin in Elderly Patients With Ischemic Stroke.
    Huang HY; Lin SY; Katz AJ; Sheu JJ; Lin FJ; Wang CC; Wu CH
    Mayo Clin Proc; 2022 Aug; 97(8):1483-1492. PubMed ID: 35933134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
    Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel two doses comparative 1-year assessment of safety and efficacy (COMPASS) study in Japanese patients with ischemic stroke.
    Uchiyama S; Tanahashi N; Minematsu K;
    Cerebrovasc Dis; 2012; 34(3):229-39. PubMed ID: 23018233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
    Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups.
    Juul N; Gislason G; Olesen JB; Lamberts M; Hansen ML; Karasoy D; Christiansen CB; Torp-Pedersen C; Sorensen R
    Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):511-521. PubMed ID: 24936092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke.
    Roumie CL; Mitchel EF; Kaltenbach L; Arbogast PG; Gideon P; Griffin MR
    Stroke; 2008 Jul; 39(7):2037-45. PubMed ID: 18436878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term bleeding events observed with clopidogrel loading in acute ischemic stroke patients.
    Leung LY; Albright KC; Boehme AK; Tarsia J; Shah KR; Siegler JE; Jones EM; Pletsch GR; Beasley TM; Martin-Schild S
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1184-9. PubMed ID: 23541421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of concomitant users of clopidogrel and proton-pump inhibitors in a high-risk population for upper gastrointestinal bleeding.
    Wang Q; Ljung R; Lagergren J; Lu Y
    BMC Pharmacol Toxicol; 2014 Apr; 15():22. PubMed ID: 24731755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of nonsteroidal anti-inflammatory drugs among healthy people and specific cerebrovascular safety.
    Fosbøl EL; Olsen AM; Olesen JB; Andersson C; Kober L; Torp-Pedersen C; Gislason GH
    Int J Stroke; 2014 Oct; 9(7):943-5. PubMed ID: 23088217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of lower gastrointestinal bleeding in low-dose aspirin users.
    Chen WC; Lin KH; Huang YT; Tsai TJ; Sun WC; Chuah SK; Wu DC; Hsu PI
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1542-1550. PubMed ID: 28449186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.